English

CARDLYTICS, INC.

EDGAR

CDLX Quarterly report (10-Q) · filed 2026-08-05

Annual consolidated revenue for 2025: about USD 233.3M, using the latest reported figures. The previous period, 2024, was about USD 278.3M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

36.9 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 36882000 USD Source

Operating margin

-14.75%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -5441000 USD Source
Revenue: 36882000 USD Source

Operating cash flow

-8.6 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -14239000 USD Source
Operating Cash Flow: -5642000 USD Source

Free cash flow

-8.6 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -14239000 USD Source
Operating Cash Flow: -5642000 USD Source
Capital Expenditure: 30000 USD Source
Capital Expenditure: 28000 USD Source

Cash and cash equivalents: 28 million USD 2026-06-30 Source
Exact value

28039000 USD
Long-term debt including current maturities: 184 million USD 2026-06-30 Source
Exact value

184411000 USD
Shares outstanding: 5.45 million shares 2026-06-30 Source
Exact value

5451000 shares

Reported share-count change

-89.37% · -45.8 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

51257000 shares · 2025-06-30· Source
5451000 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

179 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 52031000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 233273000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 177178000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 34319000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 36882000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-100 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -72673000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -103488000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -95238000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -4480000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -14876000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

532 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -3720000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -5481000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: 9290000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -3720000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -5642000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -14239000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -5642000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

69 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 455000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 441000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 480000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 455000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 28000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 30000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 28000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

463 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -3720000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -5481000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: 9290000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -3720000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -5642000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -14239000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -5642000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 455000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 441000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 480000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 455000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 28000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 30000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 28000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-05.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2025-12-31
Operating income: 10 of 11 periods available· newest 2025-12-31
Net income: 10 of 11 periods available· newest 2025-12-31
Operating cash flow: 10 of 11 periods available· newest 2025-12-31
Capital expenditure: 10 of 11 periods available· newest 2025-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 7 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 7 of 11 periods available· newest 2025-12-31
Shares outstanding: 8 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-16.2%

Prior period

USD 278.3 million

2024-01-01 – 2024-12-31
Current period

USD 233.27 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

233273000 − 278298000 = -45025000 USD

278298000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
233273000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CARDLYTICS, INC. · 2025-12-31 CARDLYTICS, INC. (edgar:1666071) Year-over-year change in Revenue: -45025000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 233273000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#2152376 Filing: 000166607126000010 Input fundies:Revenue: 278298000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#2153327 Filing: 000166607126000010
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 85.82 million

Prior period

−USD 189.3 million

2024-01-01 – 2024-12-31
Current period

−USD 103.49 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-103488000 − -189304000 = 85816000 USD

-189304000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-103488000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CARDLYTICS, INC. · 2025-12-31 CARDLYTICS, INC. (edgar:1666071) Year-over-year change in Net income: 85816000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -103488000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1283901 Filing: 000166607126000010 Input fundies:NetIncome: -189304000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1284673 Filing: 000166607126000010
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 18.11 million

Prior period

−USD 8.82 million

2024-01-01 – 2024-12-31
Current period

USD 9.29 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

9290000 − -8824000 = 18114000 USD

-8824000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
9290000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CARDLYTICS, INC. · 2025-12-31 CARDLYTICS, INC. (edgar:1666071) Year-over-year change in Operating cash flow: 18114000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 9290000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1320096 Filing: 000166607126000010 Input fundies:OperatingCashFlow: -8824000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1320748 Filing: 000166607126000010
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-69.3%

Prior period

USD 1.56 million

2024-01-01 – 2024-12-31
Current period

USD 480,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

480000 − 1562000 = -1082000 USD

1562000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
480000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CARDLYTICS, INC. · 2025-12-31 CARDLYTICS, INC. (edgar:1666071) Year-over-year change in Capital expenditure: -1082000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 480000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1322875 Filing: 000166607126000010 Input fundies:CapitalExpenditure: 1562000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1323433 Filing: 000166607126000010
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 233.27 million 100% of revenue
Operating costs Derived USD 335.09 million 144% of revenue
Operating income −USD 101.82 million −44% of revenue
Tax, interest and other Derived USD 1.67 million 0.7% of revenue
Net income −USD 103.49 million −44% of revenue

Cash

Operating cash flow USD 9.29 million 4% of revenue
Capital expenditure USD 480,000 0.2% of revenue
Free cash flow Derived USD 8.81 million 3.8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 150% of revenue.
2017 Operating loss: operating costs were 113% of revenue.
2018 Operating loss: operating costs were 127% of revenue.
2019 Operating loss: operating costs were 108% of revenue.
2020 Operating loss: operating costs were 129% of revenue.
2021 Operating loss: operating costs were 146% of revenue.
2022 Operating loss: operating costs were 253% of revenue.
2023 Operating loss: operating costs were 144% of revenue.
2024 Operating loss: operating costs were 170% of revenue.
2025 Operating loss: operating costs were 144% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	112821000	169053000 Derived	-56232000	19464000 Derived	-75696000	-34325000 Derived	Source 2016-01-01 – 2016-12-31: 112821000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -56232000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -75696000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -32498000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 1827000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	130365000	147464000 Derived	-17099000	2542000 Derived	-19641000	-23317000 Derived	Source 2017-01-01 – 2017-12-31: 130365000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -17099000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -19641000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -22102000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 1215000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	150684000	191601000 Derived	-40917000	12125000 Derived	-53042000	-24915000 Derived	Source 2018-01-01 – 2018-12-31: 150684000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -40917000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -53042000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -18995000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 5920000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	210430000	227755000 Derived	-17325000	-181000 Derived	-17144000	3180000 Derived	Source 2019-01-01 – 2019-12-31: 210430000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -17325000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -17144000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 11457000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 8277000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	186892000	240815000 Derived	-53923000	1499000 Derived	-55422000	-13006000 Derived	Source 2020-01-01 – 2020-12-31: 186892000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -53923000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -55422000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -7598000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 5408000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	267116000	389715000 Derived	-122599000	5966000 Derived	-128565000	-41631000 Derived	Source 2021-01-01 – 2021-12-31: 267116000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -122599000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -128565000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -38523000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 3108000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	298542000	756320000 Derived	-457778000	7486000 Derived	-465264000	-55075000 Derived	Source 2022-01-01 – 2022-12-31: 298542000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -457778000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -465264000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -53904000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 1171000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	309204000	444874000 Derived	-135670000	-968000 Derived	-134702000	-852000 Derived	Source 2023-01-01 – 2023-12-31: 309204000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -135670000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -134702000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -185000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 667000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	278298000	473797000 Derived	-195499000	-6195000 Derived	-189304000	-10386000 Derived	Source 2024-01-01 – 2024-12-31: 278298000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -195499000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -189304000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -8824000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 1562000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	233273000	335089000 Derived	-101816000	1672000 Derived	-103488000	8810000 Derived	Source 2025-01-01 – 2025-12-31: 233273000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -101816000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -103488000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 9290000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 480000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 233.3M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	112821000	Revenue: 112821000 Open source
20172017-12-31	Revenue	130365000	Revenue: 130365000 Open source
20182018-12-31	Revenue	150684000	Revenue: 150684000 Open source
20192019-12-31	Revenue	210430000	Revenue: 210430000 Open source
20202020-12-31	Revenue	186892000	Revenue: 186892000 Open source
20212021-12-31	Revenue	267116000	Revenue: 267116000 Open source
20222022-12-31	Revenue	298542000	Revenue: 298542000 Open source
20232023-12-31	Revenue	309204000	Revenue: 309204000 Open source
20242024-12-31	Revenue	278298000	Revenue: 278298000 Open source
20252025-12-31	Revenue	233273000	Revenue: 233273000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-16.2% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 112821000 Open source
20172017-12-31	Year over year	15.6%	Revenue: 130365000 Open source Revenue: 112821000 Open source
20182018-12-31	Year over year	15.6%	Revenue: 150684000 Open source Revenue: 130365000 Open source
20192019-12-31	Year over year	39.6%	Revenue: 210430000 Open source Revenue: 150684000 Open source
20202020-12-31	Year over year	-11.2%	Revenue: 186892000 Open source Revenue: 210430000 Open source
20212021-12-31	Year over year	42.9%	Revenue: 267116000 Open source Revenue: 186892000 Open source
20222022-12-31	Year over year	11.8%	Revenue: 298542000 Open source Revenue: 267116000 Open source
20232023-12-31	Year over year	3.6%	Revenue: 309204000 Open source Revenue: 298542000 Open source
20242024-12-31	Year over year	-10%	Revenue: 278298000 Open source Revenue: 309204000 Open source
20252025-12-31	Year over year	-16.2%	Revenue: 233273000 Open source Revenue: 278298000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -43.6% 2025

Net margin -44.4% 2025

Free cash flow margin 3.8% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-49.8%	Operating Income: -56232000 Open source Revenue: 112821000 Open source
20172017-12-31	Operating margin	-13.1%	Operating Income: -17099000 Open source Revenue: 130365000 Open source
20182018-12-31	Operating margin	-27.2%	Operating Income: -40917000 Open source Revenue: 150684000 Open source
20192019-12-31	Operating margin	-8.2%	Operating Income: -17325000 Open source Revenue: 210430000 Open source
20202020-12-31	Operating margin	-28.9%	Operating Income: -53923000 Open source Revenue: 186892000 Open source
20212021-12-31	Operating margin	-45.9%	Operating Income: -122599000 Open source Revenue: 267116000 Open source
20222022-12-31	Operating margin	-153.3%	Operating Income: -457778000 Open source Revenue: 298542000 Open source
20232023-12-31	Operating margin	-43.9%	Operating Income: -135670000 Open source Revenue: 309204000 Open source
20242024-12-31	Operating margin	-70.2%	Operating Income: -195499000 Open source Revenue: 278298000 Open source
20252025-12-31	Operating margin	-43.6%	Operating Income: -101816000 Open source Revenue: 233273000 Open source
20162016-12-31	Net margin	-67.1%	Net Income: -75696000 Open source Revenue: 112821000 Open source
20172017-12-31	Net margin	-15.1%	Net Income: -19641000 Open source Revenue: 130365000 Open source
20182018-12-31	Net margin	-35.2%	Net Income: -53042000 Open source Revenue: 150684000 Open source
20192019-12-31	Net margin	-8.1%	Net Income: -17144000 Open source Revenue: 210430000 Open source
20202020-12-31	Net margin	-29.7%	Net Income: -55422000 Open source Revenue: 186892000 Open source
20212021-12-31	Net margin	-48.1%	Net Income: -128565000 Open source Revenue: 267116000 Open source
20222022-12-31	Net margin	-155.8%	Net Income: -465264000 Open source Revenue: 298542000 Open source
20232023-12-31	Net margin	-43.6%	Net Income: -134702000 Open source Revenue: 309204000 Open source
20242024-12-31	Net margin	-68%	Net Income: -189304000 Open source Revenue: 278298000 Open source
20252025-12-31	Net margin	-44.4%	Net Income: -103488000 Open source Revenue: 233273000 Open source
20162016-12-31	Free cash flow margin	-30.4%	Revenue: 112821000 Open source Operating Cash Flow: -32498000 Open source Capital Expenditure: 1827000 Open source
20172017-12-31	Free cash flow margin	-17.9%	Revenue: 130365000 Open source Operating Cash Flow: -22102000 Open source Capital Expenditure: 1215000 Open source
20182018-12-31	Free cash flow margin	-16.5%	Revenue: 150684000 Open source Operating Cash Flow: -18995000 Open source Capital Expenditure: 5920000 Open source
20192019-12-31	Free cash flow margin	1.5%	Revenue: 210430000 Open source Operating Cash Flow: 11457000 Open source Capital Expenditure: 8277000 Open source
20202020-12-31	Free cash flow margin	-7%	Revenue: 186892000 Open source Operating Cash Flow: -7598000 Open source Capital Expenditure: 5408000 Open source
20212021-12-31	Free cash flow margin	-15.6%	Revenue: 267116000 Open source Operating Cash Flow: -38523000 Open source Capital Expenditure: 3108000 Open source
20222022-12-31	Free cash flow margin	-18.4%	Revenue: 298542000 Open source Operating Cash Flow: -53904000 Open source Capital Expenditure: 1171000 Open source
20232023-12-31	Free cash flow margin	-0.3%	Revenue: 309204000 Open source Operating Cash Flow: -185000 Open source Capital Expenditure: 667000 Open source
20242024-12-31	Free cash flow margin	-3.7%	Revenue: 278298000 Open source Operating Cash Flow: -8824000 Open source Capital Expenditure: 1562000 Open source
20252025-12-31	Free cash flow margin	3.8%	Revenue: 233273000 Open source Operating Cash Flow: 9290000 Open source Capital Expenditure: 480000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 9.3M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-32498000	Operating Cash Flow: -32498000 Open source
20172017-12-31	Operating cash flow	-22102000	Operating Cash Flow: -22102000 Open source
20182018-12-31	Operating cash flow	-18995000	Operating Cash Flow: -18995000 Open source
20192019-12-31	Operating cash flow	11457000	Operating Cash Flow: 11457000 Open source
20202020-12-31	Operating cash flow	-7598000	Operating Cash Flow: -7598000 Open source
20212021-12-31	Operating cash flow	-38523000	Operating Cash Flow: -38523000 Open source
20222022-12-31	Operating cash flow	-53904000	Operating Cash Flow: -53904000 Open source
20232023-12-31	Operating cash flow	-185000	Operating Cash Flow: -185000 Open source
20242024-12-31	Operating cash flow	-8824000	Operating Cash Flow: -8824000 Open source
20252025-12-31	Operating cash flow	9290000	Operating Cash Flow: 9290000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 8.8M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-34325000	Operating Cash Flow: -32498000 Open source Capital Expenditure: 1827000 Open source
20172017-12-31	Free cash flow	-23317000	Operating Cash Flow: -22102000 Open source Capital Expenditure: 1215000 Open source
20182018-12-31	Free cash flow	-24915000	Operating Cash Flow: -18995000 Open source Capital Expenditure: 5920000 Open source
20192019-12-31	Free cash flow	3180000	Operating Cash Flow: 11457000 Open source Capital Expenditure: 8277000 Open source
20202020-12-31	Free cash flow	-13006000	Operating Cash Flow: -7598000 Open source Capital Expenditure: 5408000 Open source
20212021-12-31	Free cash flow	-41631000	Operating Cash Flow: -38523000 Open source Capital Expenditure: 3108000 Open source
20222022-12-31	Free cash flow	-55075000	Operating Cash Flow: -53904000 Open source Capital Expenditure: 1171000 Open source
20232023-12-31	Free cash flow	-852000	Operating Cash Flow: -185000 Open source Capital Expenditure: 667000 Open source
20242024-12-31	Free cash flow	-10386000	Operating Cash Flow: -8824000 Open source Capital Expenditure: 1562000 Open source
20252025-12-31	Free cash flow	8810000	Operating Cash Flow: 9290000 Open source Capital Expenditure: 480000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

102.3% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2016-12-31	Liabilities / assets	Not reported	No source recorded
2017-12-31	Liabilities / assets	Not reported	Total Assets: 100758000 Open source
2018-12-31	Liabilities / assets	Not reported	Total Assets: 153763000 Open source
20192019-12-31	Liabilities / assets	36.1%	Total Liabilities: 81046000 Open source Total Assets: 224313000 Open source
20202020-12-31	Liabilities / assets	62.8%	Total Liabilities: 265345000 Open source Total Assets: 422537000 Open source
20212021-12-31	Liabilities / assets	45.3%	Total Liabilities: 573097000 Open source Total Assets: 1263797000 Open source
20222022-12-31	Liabilities / assets	69.4%	Total Liabilities: 479631000 Open source Total Assets: 691236000 Open source
20232023-12-31	Liabilities / assets	76.5%	Total Liabilities: 439346000 Open source Total Assets: 574144000 Open source
20242024-12-31	Liabilities / assets	82.2%	Total Liabilities: 322718000 Open source Total Assets: 392711000 Open source
20252025-12-31	Liabilities / assets	102.3%	Total Liabilities: 292149000 Open source Total Assets: 285641000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.75× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2016-12-31	Current assets / current liabilities	Not reported	No source recorded
20172017-12-31	Current assets / current liabilities	1.77×	Current Assets: 74629000 Open source Current Liabilities: 42139000 Open source
20182018-12-31	Current assets / current liabilities	2.4×	Current Assets: 124368000 Open source Current Liabilities: 51922000 Open source
20192019-12-31	Current assets / current liabilities	2.5×	Current Assets: 195730000 Open source Current Liabilities: 78401000 Open source
20202020-12-31	Current assets / current liabilities	4.74×	Current Assets: 385591000 Open source Current Liabilities: 81274000 Open source
20212021-12-31	Current assets / current liabilities	1.1×	Current Assets: 358725000 Open source Current Liabilities: 327350000 Open source
20222022-12-31	Current assets / current liabilities	1×	Current Assets: 250042000 Open source Current Liabilities: 248944000 Open source
20232023-12-31	Current assets / current liabilities	1.31×	Current Assets: 223928000 Open source Current Liabilities: 171149000 Open source
20242024-12-31	Current assets / current liabilities	1.19×	Current Assets: 177983000 Open source Current Liabilities: 148955000 Open source
20252025-12-31	Current assets / current liabilities	1.75×	Current Assets: 137279000 Open source Current Liabilities: 78390000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 75.7 million Exact value Exact value: -75696000 USD 2016-01-01 – 2016-12-31: -75696000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDLYTICS, INC. · 2016-12-31 CARDLYTICS, INC. (edgar:1666071) Net Income: -75696000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -75696000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607119000017/cdlx-20181231.xml#535165 Filing: 000166607119000017 The citation records this snapshot. The page link may show a newer release later.	−USD 32.5 million Exact value Exact value: -32498000 USD 2016-01-01 – 2016-12-31: -32498000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDLYTICS, INC. · 2016-12-31 CARDLYTICS, INC. (edgar:1666071) Operating Cash Flow: -32498000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32498000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607119000017/cdlx-20181231.xml#534231 Filing: 000166607119000017 The citation records this snapshot. The page link may show a newer release later.	USD 1.83 million Exact value Exact value: 1827000 USD 2016-01-01 – 2016-12-31: 1827000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDLYTICS, INC. · 2016-12-31 CARDLYTICS, INC. (edgar:1666071) Capital Expenditure: 1827000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1827000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607119000017/cdlx-20181231.xml#550375 Filing: 000166607119000017 The citation records this snapshot. The page link may show a newer release later.	−USD 34.33 million Calculation and evidence -32498000 − 1827000 USD Exact free cash flow: -34325000 USD 2016-01-01 – 2016-12-31: -32498000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 1827000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDLYTICS, INC. · 2016-12-31 CARDLYTICS, INC. (edgar:1666071) Free cash flow: -34325000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32498000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607119000017/cdlx-20181231.xml#534231 Filing: 000166607119000017 Input fundies:CapitalExpenditure: 1827000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607119000017/cdlx-20181231.xml#550375 Filing: 000166607119000017 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 19.64 million Exact value Exact value: -19641000 USD 2017-01-01 – 2017-12-31: -19641000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDLYTICS, INC. · 2017-12-31 CARDLYTICS, INC. (edgar:1666071) Net Income: -19641000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19641000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607120000054/cdlxform10-k2019.htm#2107738 Filing: 000166607120000054 The citation records this snapshot. The page link may show a newer release later.	−USD 22.1 million Exact value Exact value: -22102000 USD 2017-01-01 – 2017-12-31: -22102000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDLYTICS, INC. · 2017-12-31 CARDLYTICS, INC. (edgar:1666071) Operating Cash Flow: -22102000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22102000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607120000054/cdlxform10-k2019.htm#2163940 Filing: 000166607120000054 The citation records this snapshot. The page link may show a newer release later.	USD 1.22 million Exact value Exact value: 1215000 USD 2017-01-01 – 2017-12-31: 1215000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDLYTICS, INC. · 2017-12-31 CARDLYTICS, INC. (edgar:1666071) Capital Expenditure: 1215000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1215000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607120000054/cdlxform10-k2019.htm#2168736 Filing: 000166607120000054 The citation records this snapshot. The page link may show a newer release later.	−USD 23.32 million Calculation and evidence -22102000 − 1215000 USD Exact free cash flow: -23317000 USD 2017-01-01 – 2017-12-31: -22102000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 1215000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDLYTICS, INC. · 2017-12-31 CARDLYTICS, INC. (edgar:1666071) Free cash flow: -23317000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22102000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607120000054/cdlxform10-k2019.htm#2163940 Filing: 000166607120000054 Input fundies:CapitalExpenditure: 1215000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607120000054/cdlxform10-k2019.htm#2168736 Filing: 000166607120000054 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 53.04 million Exact value Exact value: -53042000 USD 2018-01-01 – 2018-12-31: -53042000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDLYTICS, INC. · 2018-12-31 CARDLYTICS, INC. (edgar:1666071) Net Income: -53042000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53042000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607121000029/cdlx-20201231.htm#1335132 Filing: 000166607121000029 The citation records this snapshot. The page link may show a newer release later.	−USD 19 million Exact value Exact value: -18995000 USD 2018-01-01 – 2018-12-31: -18995000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDLYTICS, INC. · 2018-12-31 CARDLYTICS, INC. (edgar:1666071) Operating Cash Flow: -18995000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18995000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607121000029/cdlx-20201231.htm#1399060 Filing: 000166607121000029 The citation records this snapshot. The page link may show a newer release later.	USD 5.92 million Exact value Exact value: 5920000 USD 2018-01-01 – 2018-12-31: 5920000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDLYTICS, INC. · 2018-12-31 CARDLYTICS, INC. (edgar:1666071) Capital Expenditure: 5920000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5920000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607121000029/cdlx-20201231.htm#1403070 Filing: 000166607121000029 The citation records this snapshot. The page link may show a newer release later.	−USD 24.92 million Calculation and evidence -18995000 − 5920000 USD Exact free cash flow: -24915000 USD 2018-01-01 – 2018-12-31: -18995000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 5920000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDLYTICS, INC. · 2018-12-31 CARDLYTICS, INC. (edgar:1666071) Free cash flow: -24915000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18995000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607121000029/cdlx-20201231.htm#1399060 Filing: 000166607121000029 Input fundies:CapitalExpenditure: 5920000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607121000029/cdlx-20201231.htm#1403070 Filing: 000166607121000029 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 17.14 million Exact value Exact value: -17144000 USD 2019-01-01 – 2019-12-31: -17144000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDLYTICS, INC. · 2019-12-31 CARDLYTICS, INC. (edgar:1666071) Net Income: -17144000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17144000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607122000057/cdlx-20211231.htm#1465812 Filing: 000166607122000057 The citation records this snapshot. The page link may show a newer release later.	USD 11.46 million Exact value Exact value: 11457000 USD 2019-01-01 – 2019-12-31: 11457000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDLYTICS, INC. · 2019-12-31 CARDLYTICS, INC. (edgar:1666071) Operating Cash Flow: 11457000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 11457000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607122000057/cdlx-20211231.htm#1524780 Filing: 000166607122000057 The citation records this snapshot. The page link may show a newer release later.	USD 8.28 million Exact value Exact value: 8277000 USD 2019-01-01 – 2019-12-31: 8277000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDLYTICS, INC. · 2019-12-31 CARDLYTICS, INC. (edgar:1666071) Capital Expenditure: 8277000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8277000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607122000057/cdlx-20211231.htm#1528812 Filing: 000166607122000057 The citation records this snapshot. The page link may show a newer release later.	USD 3.18 million Calculation and evidence 11457000 − 8277000 USD Exact free cash flow: 3180000 USD 2019-01-01 – 2019-12-31: 11457000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 8277000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDLYTICS, INC. · 2019-12-31 CARDLYTICS, INC. (edgar:1666071) Free cash flow: 3180000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 11457000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607122000057/cdlx-20211231.htm#1524780 Filing: 000166607122000057 Input fundies:CapitalExpenditure: 8277000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607122000057/cdlx-20211231.htm#1528812 Filing: 000166607122000057 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 55.42 million Exact value Exact value: -55422000 USD 2020-01-01 – 2020-12-31: -55422000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDLYTICS, INC. · 2020-12-31 CARDLYTICS, INC. (edgar:1666071) Net Income: -55422000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -55422000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607123000032/cdlx-20221231.htm#1548171 Filing: 000166607123000032 The citation records this snapshot. The page link may show a newer release later.	−USD 7.6 million Exact value Exact value: -7598000 USD 2020-01-01 – 2020-12-31: -7598000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDLYTICS, INC. · 2020-12-31 CARDLYTICS, INC. (edgar:1666071) Operating Cash Flow: -7598000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7598000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607123000032/cdlx-20221231.htm#1607240 Filing: 000166607123000032 The citation records this snapshot. The page link may show a newer release later.	USD 5.41 million Exact value Exact value: 5408000 USD 2020-01-01 – 2020-12-31: 5408000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDLYTICS, INC. · 2020-12-31 CARDLYTICS, INC. (edgar:1666071) Capital Expenditure: 5408000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5408000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607123000032/cdlx-20221231.htm#1611276 Filing: 000166607123000032 The citation records this snapshot. The page link may show a newer release later.	−USD 13.01 million Calculation and evidence -7598000 − 5408000 USD Exact free cash flow: -13006000 USD 2020-01-01 – 2020-12-31: -7598000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 5408000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDLYTICS, INC. · 2020-12-31 CARDLYTICS, INC. (edgar:1666071) Free cash flow: -13006000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7598000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607123000032/cdlx-20221231.htm#1607240 Filing: 000166607123000032 Input fundies:CapitalExpenditure: 5408000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607123000032/cdlx-20221231.htm#1611276 Filing: 000166607123000032 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 128.57 million Exact value Exact value: -128565000 USD 2021-01-01 – 2021-12-31: -128565000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDLYTICS, INC. · 2021-12-31 CARDLYTICS, INC. (edgar:1666071) Net Income: -128565000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -128565000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607124000037/cdlx-20231231.htm#1376248 Filing: 000166607124000037 The citation records this snapshot. The page link may show a newer release later.	−USD 38.52 million Exact value Exact value: -38523000 USD 2021-01-01 – 2021-12-31: -38523000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDLYTICS, INC. · 2021-12-31 CARDLYTICS, INC. (edgar:1666071) Operating Cash Flow: -38523000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -38523000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607124000037/cdlx-20231231.htm#1415845 Filing: 000166607124000037 The citation records this snapshot. The page link may show a newer release later.	USD 3.11 million Exact value Exact value: 3108000 USD 2021-01-01 – 2021-12-31: 3108000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDLYTICS, INC. · 2021-12-31 CARDLYTICS, INC. (edgar:1666071) Capital Expenditure: 3108000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3108000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607124000037/cdlx-20231231.htm#1418520 Filing: 000166607124000037 The citation records this snapshot. The page link may show a newer release later.	−USD 41.63 million Calculation and evidence -38523000 − 3108000 USD Exact free cash flow: -41631000 USD 2021-01-01 – 2021-12-31: -38523000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 3108000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDLYTICS, INC. · 2021-12-31 CARDLYTICS, INC. (edgar:1666071) Free cash flow: -41631000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -38523000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607124000037/cdlx-20231231.htm#1415845 Filing: 000166607124000037 Input fundies:CapitalExpenditure: 3108000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607124000037/cdlx-20231231.htm#1418520 Filing: 000166607124000037 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 465.26 million Exact value Exact value: -465264000 USD 2022-01-01 – 2022-12-31: -465264000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDLYTICS, INC. · 2022-12-31 CARDLYTICS, INC. (edgar:1666071) Net Income: -465264000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -465264000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607125000034/cdlx-20241231.htm#1324266 Filing: 000166607125000034 The citation records this snapshot. The page link may show a newer release later.	−USD 53.9 million Exact value Exact value: -53904000 USD 2022-01-01 – 2022-12-31: -53904000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDLYTICS, INC. · 2022-12-31 CARDLYTICS, INC. (edgar:1666071) Operating Cash Flow: -53904000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -53904000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607125000034/cdlx-20241231.htm#1362273 Filing: 000166607125000034 The citation records this snapshot. The page link may show a newer release later.	USD 1.17 million Exact value Exact value: 1171000 USD 2022-01-01 – 2022-12-31: 1171000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDLYTICS, INC. · 2022-12-31 CARDLYTICS, INC. (edgar:1666071) Capital Expenditure: 1171000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1171000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607125000034/cdlx-20241231.htm#1364948 Filing: 000166607125000034 The citation records this snapshot. The page link may show a newer release later.	−USD 55.08 million Calculation and evidence -53904000 − 1171000 USD Exact free cash flow: -55075000 USD 2022-01-01 – 2022-12-31: -53904000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1171000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDLYTICS, INC. · 2022-12-31 CARDLYTICS, INC. (edgar:1666071) Free cash flow: -55075000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -53904000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607125000034/cdlx-20241231.htm#1362273 Filing: 000166607125000034 Input fundies:CapitalExpenditure: 1171000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607125000034/cdlx-20241231.htm#1364948 Filing: 000166607125000034 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 134.7 million Exact value Exact value: -134702000 USD 2023-01-01 – 2023-12-31: -134702000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDLYTICS, INC. · 2023-12-31 CARDLYTICS, INC. (edgar:1666071) Net Income: -134702000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -134702000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1285445 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.	−USD 185,000 Exact value Exact value: -185000 USD 2023-01-01 – 2023-12-31: -185000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDLYTICS, INC. · 2023-12-31 CARDLYTICS, INC. (edgar:1666071) Operating Cash Flow: -185000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -185000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1321404 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.	USD 667,000 Exact value Exact value: 667000 USD 2023-01-01 – 2023-12-31: 667000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDLYTICS, INC. · 2023-12-31 CARDLYTICS, INC. (edgar:1666071) Capital Expenditure: 667000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 667000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1324022 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.	−USD 852,000 Calculation and evidence -185000 − 667000 USD Exact free cash flow: -852000 USD 2023-01-01 – 2023-12-31: -185000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 667000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDLYTICS, INC. · 2023-12-31 CARDLYTICS, INC. (edgar:1666071) Free cash flow: -852000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -185000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1321404 Filing: 000166607126000010 Input fundies:CapitalExpenditure: 667000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1324022 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 189.3 million Exact value Exact value: -189304000 USD 2024-01-01 – 2024-12-31: -189304000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDLYTICS, INC. · 2024-12-31 CARDLYTICS, INC. (edgar:1666071) Net Income: -189304000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -189304000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1284673 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.	−USD 8.82 million Exact value Exact value: -8824000 USD 2024-01-01 – 2024-12-31: -8824000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDLYTICS, INC. · 2024-12-31 CARDLYTICS, INC. (edgar:1666071) Operating Cash Flow: -8824000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8824000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1320748 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.	USD 1.56 million Exact value Exact value: 1562000 USD 2024-01-01 – 2024-12-31: 1562000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDLYTICS, INC. · 2024-12-31 CARDLYTICS, INC. (edgar:1666071) Capital Expenditure: 1562000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1562000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1323433 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.	−USD 10.39 million Calculation and evidence -8824000 − 1562000 USD Exact free cash flow: -10386000 USD 2024-01-01 – 2024-12-31: -8824000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 1562000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDLYTICS, INC. · 2024-12-31 CARDLYTICS, INC. (edgar:1666071) Free cash flow: -10386000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8824000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1320748 Filing: 000166607126000010 Input fundies:CapitalExpenditure: 1562000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1323433 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 103.49 million Exact value Exact value: -103488000 USD 2025-01-01 – 2025-12-31: -103488000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDLYTICS, INC. · 2025-12-31 CARDLYTICS, INC. (edgar:1666071) Net Income: -103488000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -103488000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1283901 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.	USD 9.29 million Exact value Exact value: 9290000 USD 2025-01-01 – 2025-12-31: 9290000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDLYTICS, INC. · 2025-12-31 CARDLYTICS, INC. (edgar:1666071) Operating Cash Flow: 9290000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9290000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1320096 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.	USD 480,000 Exact value Exact value: 480000 USD 2025-01-01 – 2025-12-31: 480000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDLYTICS, INC. · 2025-12-31 CARDLYTICS, INC. (edgar:1666071) Capital Expenditure: 480000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 480000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1322875 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.	USD 8.81 million Calculation and evidence 9290000 − 480000 USD Exact free cash flow: 8810000 USD 2025-01-01 – 2025-12-31: 9290000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 480000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDLYTICS, INC. · 2025-12-31 CARDLYTICS, INC. (edgar:1666071) Free cash flow: 8810000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-03T18:55:21Z Snapshot: 8d5594c3d0699dc3b944a5e09bab074fa952f86a51b7abac5d125ed5e504975c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1666071?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9290000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1320096 Filing: 000166607126000010 Input fundies:CapitalExpenditure: 480000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1666071/000166607126000010/cdlx-20251231.htm#1322875 Filing: 000166607126000010 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

129 filings · 3,282 latest values · 3,282 originally reported values

Dataset published 2026-11-03. Source filing dates and reporting periods are shown separately.

Identifiers: 0001666071, 1666071, CDLX, edgar:1666071

Also known as CARDLYTICS, INC., CARDLYTICS, INC., Cardlytics, Inc., Cardlytics, Inc.

CARDLYTICS, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation